DOREMI
2021
Milrinone versus Dobutamine in Cardiogenic Shock
In 192 patients with cardiogenic shock, milrinone produced similar rates of death and major complications compared with dobutamine.
Result
Primary endpoint: Composite of death, resuscitated arrest, mechanical support and other events
No significant difference between the two inotropes.
- Subtopic
- Inotropes
- Design
- Double-blind RCT
- Relevance
- Supporting: context rather than must-know.
- Also listed in
- Cardiogenic shock & MCS
- Source
- Mathew R, et al. N Engl J Med. 2021;385(6):516-525.doi 10.1056/NEJMoa2026845
Discussion & critique
No winning inotrope in cardiogenic shock: the choice is by patient characteristics and side-effect profile, not outcomes.